After deleted the data, the results indicated CCND2‐positive expression was an important adverse predictor of OS in cancer patients (pooled HR = 2.21, 95% CI: 1.67‐2.93, P = 0.799) (Figure 4A). The gene discussed is CCND2; the disease is cancer.